Clinical Trial Update: Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

View source ↗

Summary

A clinical trial is examining whether circulating tumor DNA (ctDNA) assessment can predict response to neoadjuvant therapy in breast cancer and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gene Solutions | Conditions: Breast Cancer Female, Stage II Breast Cancer | Status: RECRUITING